High prevalence of maternal mosaic monosomy X in pregnant women in Vietnam

J Matern Fetal Neonatal Med. 2023 Dec;36(1):2155044. doi: 10.1080/14767058.2022.2155044. Epub 2022 Dec 13.

Abstract

Objective: To demonstrate the prevalence of maternal mosaic monosomy X (MMXO) in a cohort of pregnant women in Vietnam.

Methods: All 105,594 singleton pregnant women undergoing noninvasive prenatal screening (NIPS) between January 2019 and February 2021 in Vietnam were analyzed by measuring discordance between size- and count-based z-scores for chromosome X (ChrX) to identify suspected cases of MMXO and validated by fluorescence in situ hybridization (FISH) on maternal blood.

Results: We identified 295 (0.279%) suspected MMXO cases. After FISH analysis, MMXO was confirmed in 125 cases (42.37%), revealing the MMXO prevalence of 0.118% (95% CI: 0.097-0.139%) in this cohort.

Conclusion: We found a relatively high prevalence of MMXO in Vietnamese pregnant women and demonstrated a strong influence of MMXO on the ChrX z-score using a count-based method, resulting in false positives. The size-based method is not sensitive to MMXO and therefore achieves higher PPV.

Keywords: Maternal mosaic monosomy; Vietnam; chromosome X; pregnant women; z-score.

MeSH terms

  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Pregnancy
  • Pregnant Women
  • Prenatal Diagnosis / methods
  • Prevalence
  • Turner Syndrome* / diagnosis
  • Turner Syndrome* / epidemiology
  • Turner Syndrome* / genetics
  • Vietnam / epidemiology